ArticleCells2024

IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol.

Richard E KastPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.